Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
- 312 Downloads
Purpose of Review
Type 2 diabetes (T2D) is a growing public health problem in youth, but conventional treatments are often insufficient to treat this disease and its comorbidities. We review evidence supporting an emerging role for bariatric surgery as a treatment for adolescent T2D.
Paralleling what has been seen in adult patients, bariatric surgery dramatically improves glycemic control in patients with T2D. In fact, remission of T2D has been observed in as many as 95–100% of adolescents with diabetes after bariatric surgery, particularly vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB) surgery. This striking outcome may be due to both weight-dependent- and weight-independent factors, and recent studies suggest that T2D-related comorbidities may also improve after surgery.
Bariatric surgery including RYGB and VSG is a powerful therapeutic option for obese adolescents with T2D. Benefits must be weighed against risk for postoperative complications such as nutritional deficiencies, but earlier surgical intervention might lead to more complete metabolic remission in obese patients with T2D.
KeywordsBariatric surgery Type 2 diabetes Obesity Adolescent Roux-en-Y gastric bypass surgery Sleeve gastrectomy
Dr. Stefater has received research grants from the Pediatric Endocrine Society and the Endocrine Fellows Foundation. Her training is also funded by an institutional T32 (DK007699) training grant.
Dr. Inge has received grants from the National Institute of Diabetes and Digestive and Kidney Diseases.
Compliance with Ethical Standards
Conflict of Interest
Dr. Stefater declares that she has no conflict of interest.
Dr. Inge has been a consultant for Standard Bariatric and UpToDate.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human participants or animals performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Association AD. Statistics about diabetes 2017. 2017. Available from: http://www.diabetes.org/diabetes-basics/statistics/?referrer=https://www.google.com/.
- 3.Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12):2515–20.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 20(1):50–5.Google Scholar
- 12.Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc. 2011.Google Scholar
- 16.•• Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Helmrath MA, Brandt ML, et al. Weight loss and health status 3 years after bariatric surgery in adolescents. N Engl J Med. 2016;374(2):113–23. A part of the Teen-LABS study, this was the first large (242 patients), prospective study of outcomes 3 years after sleeve gastrectomy or RYGB in adolescents CrossRefPubMedGoogle Scholar
- 27.Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 6(2):102–9.Google Scholar
- 29.• Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA surgery. 2015;150(10):931–40. A part of the LABS study, the adult correlate to the Teen-LABS study, this was a large, prospective study examining the impact of RYGB and AGB versus lifestyle intervention in adult diabetic patients CrossRefPubMedPubMedCentralGoogle Scholar
- 32.• Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Eng J Med. 2017;376(7):641–51. A prospective study of 134 adult patients followed 5 years after bariatric surgery showed superior rates of diabetes remission amongst patients treated with VSG or RYGB, as compared with intensive medical therapy CrossRefGoogle Scholar
- 41.•• Inge TH, Jenkins TM, Xanthakos SA, Dixon JB, Daniels SR, Zeller MH, et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 2017;5(3):165–73. Five-year outcomes of the Teen-LABS study, a large prospective study of adolescent bariatric surgery CrossRefPubMedGoogle Scholar
- 49.Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–7.CrossRefPubMedGoogle Scholar
- 50.Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis. 2011.Google Scholar
- 51.Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis. 2011.Google Scholar
- 64.US Renal Data System. USRDS 2014 annual data report: atlas of end-stage renal disease in the United States [press release]. Bethesda: National Institute of Diabetes and Digestive Kidney Diseases; 2014.Google Scholar
- 73.Carlsson LM, Sjoholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, et al. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2017.Google Scholar
- 93.Jeffreys RM, Hrovat K, Woo JG, Schmidt M, Inge TH, Xanthakos SA. Dietary assessment of adolescents undergoing laparoscopic Roux-en-Y gastric bypass surgery: macro- and micronutrient, fiber, and supplement intake. Surg Obes Relat Dis. 2011.Google Scholar
- 99.Schafer AL. Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol. 2016.Google Scholar